ELC Convenes Medical Advisory Board to Guide Company’s COVID-19 Response

The Estée Lauder Companies (ELC) has convened a Medical Advisory Board to inform its responses to the current COVID-19 pandemic. Comprised of leading doctors and health professionals with expertise across a variety of disciplines, the Medical Advisory Board is working closely with the Company’s internal Health and Safety Team and Company leaders to guide ELC’s health and safety related efforts.

“Immediate access to best-in-class medical professionals was deemed critical as the Company prioritises the health and wellbeing of our employees and our consumers during these challenging, unprecedented times,” said Carl Haney, Executive Vice President, Global Research & Development, Corporate Product Innovation, Package Development. “As a Company founded upon family values, the convening of a Medical Advisory Board is an expression of these values, to serve us now and well into the future.” 

The Role of the Medical Advisory Board

The Medical Advisory Board has been working with ELC leaders to review current health and safety policies and protocols, providing crucial insights where appropriate, including guidance for laboratories, manufacturing facilities, retail stores and counters, and corporate offices. They have also been advising on daily matters related to workplace-specific COVID-19 health issues, helping to interpret the guidance issued by the WHO, CDC and other health authorities, as it applies to ELC.

Informing Long-Term Health & Safety Strategy

Looking ahead, the Medical Advisory Board will collaborate with the Company to inform longer-term policies related to employee and consumer health and safety, and business scenario planning from a health and welfare perspective.

“As the impact of COVID-19 persists in areas around the world, our work with this exceptional group of doctors will be invaluable as we continue to prioritise protecting our employees and our consumers while we ensure the longevity of our business,” added Carl.